# A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

> **NCT00441558** · PHASE3 · TERMINATED · sponsor: **Sprout Pharmaceuticals, Inc** · enrollment: 1723 (actual)

## Conditions studied

- Sexual Dysfunctions, Psychological

## Interventions

- **DRUG:** Flibanserin

## Key facts

- **NCT ID:** NCT00441558
- **Lead sponsor:** Sprout Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 1723 (ACTUAL)
- **Why stopped:** terminated for administrative reasons
- **Last updated:** 2014-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441558, "A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00441558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*